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Abstract Flavonoids are potent antioxidants and have been
associated with lowering the risk of cardiovascular diseases. In
this study, the effect of flavonoids (monomers, dimers and a
trimer) as well as French maritime pine bark extract,
Pycnogenol, on NO production, tumor necrosis factor-K (TNF-
K) secretion and nuclear factor (NF)-UB activity was compared.
Monomers and dimers repressed NO production, TNF-K
secretion and NF-UB-dependent gene expression induced by
interferon Q, whereas the trimeric procyanidin C2 and Pycno-
genol enhanced these parameters. In addition, in unstimulated
RAW 264.7 macrophages, both procyanidin C2 and Pycnogenol
increased TNF-K secretion in a concentration- and time-
dependent manner. These results demonstrate that procyanidins
act as modulators of the immune response in macrophages.
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1. Introduction
Activated macrophages can generate large amounts of NO
from L-arginine by the action of inducible NO synthase
(iNOS). NO is an important intracellular and intercellular
regulatory molecule of multiple biological functions, including
macrophage-mediated cytotoxicity, neurotransmission, and
smooth muscle relaxation [1,2]. Overproduction of NO has
been associated with oxidative stress [3,4] and with the path-
ophysiology of various diseases such as arthritis, diabetes,
stroke, septic shock, autoimmune disease, and chronic in£am-
mation [5,6]. Cytokines such as interferon-Q (IFN-Q), interleu-
kin (IL)-2, and other in£ammatory stimuli such as bacterial
lipopolysaccharide (LPS) regulate the activity of iNOS in
macrophages [7,8]. It has also been shown that the production
of tumor necrosis factor-K (TNF-K) is crucial for the syner-
gistic induction of NO synthesis in IFN-Q and/or LPS-stimu-
lated macrophages [9,10].
In macrophages, nuclear factor UB (NF-UB) in cooperation
with other transcription factors coordinates the expression of
genes encoding both iNOS and TNF-K. NF-UB plays a critical
role in the activation of immune cells by upregulating the
expression of many cytokines essential to the immune re-
sponse [11]. In particular, NF-UB stimulates the production
of IL-1, IL-6, TNF-K, lymphotoxin, and IFN-Q. Furthermore,
some of these cytokines, e.g. IL-1 and TNF-K, activate NF-UB
themselves, thus initiating an autoregulatory feedback loop.
NF-UB activation by various stimuli occurs upon its dissoci-
ation from the inhibitory protein IUB and its subsequent nu-
clear translocation. Several lines of evidence, including the
inhibition by various antioxidants, suggest that NF-UB acti-
vation is subject to redox regulation [12,13]. Because of the
pivotal role of NO and TNF-K in the antimicrobial and tu-
moricidal activities of macrophages, a signi¢cant e¡ort has
focused on developing therapeutic agents that regulate NO
production and TNF-K secretion [14].
Epidemiological reports have indicated that consumption of
foods rich in £avonoids is associated with a lower incidence of
degenerative diseases. Consistently, experimental data are ac-
cumulating regarding phenolic compounds as natural phyto-
chemical antioxidants that possess antiin£ammatory, antivi-
ral, antiproliferative, and anticarcinogenic properties [15,16].
There is increasing interest in the biological activities of plant
extracts such as that obtained from the bark of the French
maritime pine, Pinus maritima. Pine bark extract (Pycnogenol,
PYC) is a unique mixture of phenols and polyphenols,
broadly divided into monomers (e.g. catechin, epicatechin
and taxifolin), dimers (e.g. procyanidin B1, B2, B3, and B7),
trimers (e.g. procyanidin C1, C2), and oligomers up to 5^7
units. PYC also contains phenolic acids such as ca¡eic, ferulic
and p-hydroxybenzoic acid as minor constituents [17]. Bio£a-
vonoids participate in an antioxidant network [18] and likely
spare endogenous cellular vitamin E [19] and glutathione [20].
PYC also modulates NO metabolism in stimulated macro-
phages by a¡ecting both iNOS mRNA expression and iNOS
activity [21]. However, little is known about which particular
constituents of PYC mediate its immunomodulatory proper-
ties. Therefore, the objective of the present study was to in-
vestigate whether puri¢ed monomeric, dimeric, and trimeric
£avonoids in comparison to PYC can modulate NF-UB acti-
vation as well as NO production and TNF-K secretion in
RAW 264.7 macrophages.
2. Materials and methods
2.1. Materials
Murine recombinant IFN-Q (1U106 U/mg), murine recombinant
TNF-K (1U106 U/ml), rabbit anti-murine TNF-K polyclonal antibody
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(Ab), and hamster anti-murine TNF-K monoclonal Ab were from
Genzyme (Munich, Germany). LPS (phenol-extracted Salmonella en-
teritidis), catechin, epicatechin, and taxifolin were from Sigma Chem-
ical Co. (St. Louis, MO, USA). Fetal calf serum and antibiotics were
from the University of California, San Francisco Cell Culture Facility.
RPMI containing L-arginine (200 mg/l), Hanks’ balanced salt solu-
tion, and other tissue culture reagents were purchased from Life Tech-
nologies (Gaithersburg, MD, USA). Pycnogenol was a gift from Hor-
phag Research Ltd. (Guernsey, UK). Procyanidins B1, B2 (both from
apples, 98% purity), and C2 (from barley, 93% purity) were a gift
from Tsukuba Research Laboratories (Kyowa Hakko Kogyo, Japan).
2.2. Macrophage culture
The murine monocyte/macrophage cell line RAW 264.7 was ob-
tained from the American Type Culture Collection (Rockville, MD,
USA). Cells were cultured in 75-cm2 plastic £asks (Falcon-Becton
Dickinson Labwares, Franklin Lakes, NJ, USA) and maintained in
RPMI 1640 supplemented with 10% (v/v) fetal calf serum and anti-
biotics (100 U/ml of penicillin, 100 Wg/ml of streptomycin). For ex-
periments, macrophages were detached by vigorous pipetting and,
after centrifugation, incubated with fresh medium in either 96-well
tissue culture plates (2U105 cells/well) or 24-well tissue culture plates
(5U105 cells/well) at 37‡C in an atmosphere of 5% CO2 plus air. Cells
were supplemented with the test compounds for 1 h followed by their
stimulation with 10 U/ml IFN-Q and further incubated for various
periods as described in Section 3.
2.3. Neutral red assay
Uptake of the dye neutral red was used as a measure of cell viability
[22]. Cells were plated in 24-well plates, and samples were treated for
24 h in 500 Wl of medium. Thereafter, the medium was removed and
replaced with 500 Wl of medium containing 60 Wg/ml of neutral red
(Fisher Scienti¢c, Pittsburgh, PA, USA) for 3 h at 37‡C. Following
incubation with the neutral red dye, the medium was removed, and
the cells were extracted with 500 Wl of 50% ethanol, 49% H2O, 1%
glacial acetic acid, pH 4.2. Quadruplicate 100-Wl samples from each
well were transferred to a 96-well plate, and the absorbance at 510 nm
was measured with a microplate reader (CS-931, Shimadzu Corpora-
tion, Columbia, MD, USA).
2.4. Assay of TNF-K secretion
TNF-K secretion was measured by modi¢cation of an enzyme-
linked immunosorbent assay (ELISA), as described earlier [23]. For
the ELISA, 96-well plates were coated with 6.25 ng/well of murine
monoclonal Ab with speci¢city for murine TNF-K. Before use and
between subsequent steps in the assay, coated plates were washed
twice with phosphate-buufered saline (PBS) containing 0.05% (v/v)
Tween-20 and twice with PBS alone. For the standard curve, rTNF-
K was added to serum previously determined to be negative for en-
dogenous TNF-K. After exposure to medium, assay plates were se-
quentially exposed to rabbit anti-TNF-K, phosphatase-conjugated
goat anti-rabbit IgG, and p-nitrophenyl phosphate. Optical density
readings at 410 nm were taken using a microplate reader.
2.5. Measurement of nitrite and nitrate concentration
NO secretion in cultured macrophages was measured by a micro-
plate assay method, as described earlier [24,25]. To measure nitrite
(NO32 ), 100 Wl of macrophage culture supernatant was collected,
mixed with an equal volume of Griess reagent (1% sulfanilamide/
0.1% N-(1-naphthyl)-ethylenediamine dihydrochloride/2.5% H3PO4)
and incubated for 10 min at room temperature. Nitrite concentration
was determined by measuring the absorbance at 540 nm. NaNO2 was
used for external calibration. Cell-free medium alone contained 5^8
WM of nitrite; this value was determined in each experiment and
subtracted from the value obtained for each cell sample. Nitrate
(NO33 ) was measured by reducing nitrate to nitrite with bacterial
nitrate reductase, then measuring nitrite by using Griess reagent.
There was no interference of the test compounds either with the ELI-
SA or with Griess reagent.
2.6. Cell transfection and reporter gene assay
RAW 264.7 macrophages were plated at 2U105 cells per cm2 in 12-
well plates, and 24 h later transiently co-transfected with the plasmids
pGL3-4UB-Luc and pRL-TK (reference plasmid containing a Renilla
luciferase gene driven by a minimal thymidine kinase promoter,
Promega, Madison, WI, USA) using Fugene 6 reagent (Roche Mo-
lecular Biochemicals, Indianapolis, IN, USA) according to the man-
ufacturer’s protocol. Brie£y, the transfection mixture containing 0.35
Wg of pGL3-4UB-Luc and 0.15 Wg of pRL-TK was mixed with the
Fugene 6 reagent and added to the cells. Treatments with test com-
pounds and IFN-Q were started 18 h after transfection. Cell lysis was
performed 12 h after treatments and luciferase activities were mea-
sured using the dual-luciferase reporter assay system (Promega) with
an LKB/Wallac luminometer 1250 (Wallac, Gaithersburg, MD,
USA). The dual-luciferase system is based on the subsequent measure-
ment of ¢re£y (from pGL3-4UB-Luc) and Renilla (from pRL-TK)
luciferase activities in the same tube with the same extract. The ¢re£y
luciferase activity was normalized in that system with the Renilla
luciferase activity to correct for di¡erences in the transfection e⁄-
ciency [26].
2.7. Lipid A analysis
PYC was tested for the presence of lipid A. Samples and reference
standard (deep rough chemotype LPS from Escherichia coli D31m4)
were treated with EDTA, and puri¢ed by a DEAE-cellulose column
chromatography as previously described [27]. Samples were hydro-
lyzed in 2 ml of 0.1 M HCl at 100‡C for 30 min to yield monophos-
phoryl lipid A. Then 5 ml of chloroform/methanol (2:1, v/v) was
added, mixed and centrifuged. The lower organic layer was recovered,
¢ltered and dried. The extracted samples were applied in chloroform/
methanol (4:1, v/v) to silica gel GHL plate (250 Wm) and irrigated
with chloroform/methanol/water/concentrated ammonium hydroxide
(50:25:4:2, v/v). Spots were visualized by spraying the plate with
dichromate/sulfuric acid reagent and charring.
2.8. Statistics or reproducibility
Data in ¢gures are the mean þ S.D. of at least three di¡erent experi-
ments performed in triplicate.
3. Results
3.1. TNF-K secretion by macrophages is modi¢ed by £avonoids
in a structure-dependent manner
As a ¢rst step, the cytotoxic activity of the monomeric,
dimeric and trimeric £avonoids as well as PYC in the absence
and presence of IFN-Q was assessed using the neutral red
assay. Pretreatment of both unstimulated and stimulated
RAW 264.7 macrophages up to 100 Wg/ml catechin, epicate-
chin as well as PCA B1, PCA B2 and PCA C2 did not
signi¢cantly a¡ect the cell viability (data not shown). How-
ever, in macrophages treated with 100 Wg/ml taxifolin for 24 h
a slight although signi¢cant cytotoxic e¡ect could be ob-
served.
In unstimulated macrophages only small amounts of TNF-
K were secreted into the medium (Fig. 1A). Pretreatment of
unstimulated cells with monomeric or dimeric £avonoids over
24 h did not result in any change in the secretion of TNF-K
into the medium. However, in the presence of PCA C2 or
PYC the secreted levels of TNF-K signi¢cantly increased.
The stimulation of RAW 264.7 cells with IFN-Q resulted in
a manifold increase in TNF-K secretion monitored 24 h after
administration (Fig. 1B). All monomeric £avonoids tested
(catechin, epicatechin, and taxifolin) decreased the secretion
of TNF-K almost down to the baseline levels as measured in
the unstimulated control cells. While the dimeric £avonoids
PCA B1 and PCA B2 slightly inhibited IFN-Q-induced TNF-K
secretion, the trimeric £avonoid PCA C2 induced about a
two-fold increase in the secretion of TNF-K in IFN-Q-stimu-
lated macrophages. Similar to PCA C2, PYC potentiated the
e¡ect of IFN-Q on TNF-K secretion.
The secretion of TNF-K due to PCA C2 and PYC increased
both in a dose- and time-dependent fashion as shown in Fig.
2A,B, respectively.
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3.2. E¡ect of monomeric, dimeric, and trimeric £avonoids on
NO production in IFN-Q-stimulated macrophages
In parallel with the characterization of TNF-K secretion the
e¡ect of the di¡erent £avonoids on NO release into the me-
dium measured by the Griess reaction was studied. Unstimu-
lated control cells produced a negligible amount of NO (6 5
WM). However, in IFN-Q-stimulated cells a substantial in-
crease in the production of NO was evident (Fig. 3). Pretreat-
ment of macrophages with catechin, epicatechin, and taxifolin
Fig. 1. E¡ect of structure-related £avonoids on TNF-K secretion in
unstimulated (A) and IFN-Q-stimulated (B) RAW 264.7 macro-
phages. The cells were incubated for 24 h in the presence or absence
of several pure £avonoids, PYC, or LPS. Then, supernatants were
collected, and the amount of TNF-K secreted by macrophages was
measured by speci¢c ELISA. All £avonoids tested in this and all
further experiments were supplemented at a concentration of 100
Wg/ml (corresponds to the following concentrations in WM: catechin
and epicatechin = 344, procyanidin B1 and B2 = 173, procyanidin
C2 = 115) whereas taxifolin was supplemented at 50 Wg/ml (164
WM). Values are means þ S.D. of three independent cell preparation.
Fig. 2. A: Dose-dependent e¡ect of PCA C2 (b) and PYC (R) on
TNF-K secretion in unstimulated macrophages. The cells were incu-
bated for 24 h in the presence or absence of various concentrations
of £avonoids. B: Time-dependent e¡ect of PCA C2 and PYC on
TNF-K secretion in macrophages. At the indicated time points after
treatment of £avonoids supernatants were collected, and the amount
of TNF-K secreted by macrophages was determined with an ELISA.
Values are means þ S.D. of three experiments.
Fig. 3. E¡ect of structure-related £avonoids on NO production in
IFN-Q-stimulated macrophages. The cells were incubated as de-
scribed in Fig. 2. Then, the amounts of nitrite and nitrate released
by macrophages were measured 24 h after stimulation by the meth-
od of Griess. Results are presented as means þ S.D. of three inde-
pendent cell preparation.
Fig. 4. A: E¡ect of structure-related £avonoids on NF-UB-depen-
dent luciferase gene expression in IFN-Q-stimulated macrophages.
After co-transfection, the cells were washed twice and incubated as
described in Fig. 2. Then, the cells were lysed 24 h after stimulation.
The dual-luciferase assay was performed and luciferase activity ex-
pressed as relative to that of the control (untreated cells). B: E¡ect
of anti-TNF-K neutralizing Ab on rIFN-Q- or rIFN-Q+PCA C2-, or
rIFN-Q+PYC-induced NF-UB-dependent gene expression in macro-
phages. After co-transfection, anti-TNF-K neutralizing Ab (dilution,
1:50) was added to the culture medium for 15 min. The cells were
then treated with rIFN-Q (10 U/ml) or PCA C2 or PYC for 24 h
prior to cell lysis. The data are presented as means from three inde-
pendent experiments, each performed in duplicate.
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signi¢cantly decreased IFN-Q-induced NO production by 40,
60, and 75%, respectively, as compared to IFN-Q-treated cells.
The dimeric £avonoids PCA B1 and PCA B2 showed a mod-
erate inhibitory e¡ect on NO production. In contrast to the
monomeric and dimeric procyanidins pretreatment of IFN-Q-
stimulated macrophages with the PCA C2 as well as PYC
signi¢cantly increased IFN-Q-induced NO production.
3.3. NF-UB-dependent gene expression in IFN-Q-stimulated
macrophages is modulated by £avonoids
Induction of TNF-K and iNOS is modulated, in part
through the activation of NF-UB. Consequently the e¡ect of
di¡erent £avonoids on NF-UB-dependent gene expression us-
ing the dual-luciferase reporter gene assay was studied. Nearly
a two-fold increase in luciferase activity was observed when
RAW 264.7 macrophages were stimulated with IFN-Q as com-
pared to unstimulated control cells (Fig. 4A). Similar to the
data for TNF-K secretion and NO production the monomeric
£avonoids catechin, epicatechin and taxifolin completely
counteracted IFN-Q-induced NF-UB transactivation. Pretreat-
ment of macrophages with PCA B1 and PCA B2 resulted in a
slight decrease in the luciferase activity. However, di¡erent to
the monomers and dimers, PCA C2 and PYC signi¢cantly
increased luciferase activity in IFN-Q-stimulated cells. In addi-
tion both PCA C2- and PYC-induced NF-UB activation was
totally inhibited by the use of a anti-murine TNF-K-neutral-
izing Ab, indicating that PCA C2 or PYC-induced TNF-K




TNF-K was produced in vanishingly small quantities in
unstimulated cells as reported previously [28]. However,
when macrophages were stimulated with IFN-Q, a manifold
increase in the secretion of TNF-K into the medium was ob-
served. Interestingly, both in the absence and in the presence
of IFN-Q, pretreatment of macrophages with the trimer PCA
C2 as well as PYC substantially elevated TNF-K release from
undetectable levels up to 2^4 ng/ml. Similar to PCA C2 and
PYC the £avonoid drug £avone-8-acetic acid (FAA), which
augments mouse natural killer activity, has been shown to
induce TNF-K secretion in J774 cells and thereby synergized
with recombinant IL-2 for the treatment of murine renal can-
cer [29]. Moreover, the red wine polyphenol resveratrol has
been reported to have a potent e¡ect to increase basal TNF-K
mRNA expression with a concomitant increase in TNF-K
secretion in RAW 264.7 macrophages [30]. In this regard it
is hypothesized that TNF-K induction appears to be one crit-
ical factor in the antitumor e¡ects of this class of compounds.
However, in contrast to PCA C2 and PYC the monomeric
£avonoids (catechin, epicatechin, and taxifolin) tested in the
present study had a strong and the dimeric £avonoids PCA
B1 and PCA B2 a slight inhibitory e¡ect on the secretion of
TNF-K into the medium. Consistent with these ¢ndings green
tea polyphenols also signi¢cantly decreased TNF-K and NO
synthesis in elicited murine peritoneal macrophages as well as
in the BALB/c mouse model [31]. The underlying mechanisms
by which di¡erent £avonoids result in a di¡erent outcome in
terms of TNF-K secretion and NO production have not been
clari¢ed yet.
4.2. NO production
The monomeric £avonoids catechin, epicatechin, and taxi-
folin signi¢cantly inhibited NO production in IFN-Q-stimu-
lated cells. The cellular mechanisms by which £avonoids
down-regulate NO production are not completely understood.
It is suggested that this e¡ect might be partially mediated due
to the combination of several di¡erent biological activities, i.e.
NO scavenging activity, inhibition of iNOS enzyme activity,
and inhibition of iNOS mRNA expression [32]. It should also
be taken into consideration that macrophages are often stimu-
lated with LPS in order to ensure a high production of NO.
However, stimulation of macrophages with LPS in the pres-
ence of £avonoids seems to be problematic since £avonoid-
rich extracts have been recently found to suppress the activity
of LPS and lipid A preparations regardless of the origin of the
bacteria in the Limulus test [33] widely used for diagnosis of
Gram-negative bacterial endotoxins. It is suggested that an
inhibition in the production of NO is not exclusively mediated
due to cellular e¡ects of the £avonoids per se but might also
be partially caused by a direct interaction of these compound
with the LPS molecule. Therefore in the present investigation
macrophages were stimulated with IFN-Q only.
In contrast to the monomeric and dimeric £avonoids, PCA
C2 and PYC signi¢cantly increased the production of NO in
IFN-Q-stimulated macrophages. Under the conditions investi-
gated, treatment of unstimulated macrophages with PCA C2
and PYC also resulted in a considerable increase in TNF-K
secretion into the medium known to be crucial for NO syn-
thesis in macrophages. Based on monophosphoryl lipid A
analysis PYC was completely devoid of lipid A. This ¢nding
suggests that PYC contains no signi¢cant amounts of Gram-
negative bacterial-type LPS to contribute to its biological ac-
tivities in terms of NO production, TNF-K secretion and NF-
UB activation. In the absence of IFN-Q both treatment of
macrophages with PCA C2 and PYC alone resulted in a con-
siderable activation of NF-UB (Fig. 4B) that was signi¢cantly
inhibited by the use of anti-murine TNF-K Ab. These data
indicate that PCA C2- and PYC-induced changes in TNF-K
secretion are at least partially responsible for the observed
di¡erence in NF-UB activation which again can a¡ect NO
synthesis.
4.3. NF-UB-dependent gene expression
The biosynthesis of TNF-K is tightly controlled by di¡erent
molecular events regulating the TNF-K gene, mRNA and
protein. At the transcriptional level, besides a TATA box
promoter located 20 bp upstream of the transcription start
site, a number of regulatory sequences are also found up-
stream of the TNF-K gene, including three NF-UB sites U1,
U2, U3 which are thought to be implicated in the mechanism
of TNF-K induction. Furthermore, two upstream DNA re-
gions of the iNOS promoter, the RI and RII domains, are
required for the maximal promoter activation by LPS, and the
RII domain mediates promoter trans-activation of IFN-Q.
Both of these domains comprise multiple sequences homolo-
gous to those of cis elements involved in transcription activa-
tion, such as NF-UB binding sites, IFN-Q response elements,
and IFN-Q-activated factor binding [34]. Therefore, we sought
to study the e¡ect of di¡erent structure-related £avonoids in
terms of NF-UB-dependent gene expression using the dual-
luciferase reporter gene assay.
Consistent with data for both TNF-K and NO, the mono-
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meric £avonoids decreased whereas PCA C2 and PYC in-
creased NF-UB-dependent gene expression indicating that dif-
ferences in TNF-K secretion and NO production might be
partially mediated due to di¡erence in the activation or inhibi-
tion of NF-UB. Although no common second messenger has
been identi¢ed, many NF-UB-activating signals have been
shown to be inhibited by antioxidants. Plumb et al. [35] re-
cently studied the antioxidant properties of catechin, epicate-
chin as well as structure-related dimeric and trimeric £avo-
noids similar to those used in the present study.
Interestingly, the antioxidant activity in the aqueous phase
increased from monomeric to trimeric £avonoids. However,
in the present study the trimeric £avonoid PCA C2 as well as
PYC induced a substantial activation of NF-UB. Hence
changes in NF-UB-dependent gene expression due to £avo-
noids do not necessarily re£ect di¡erences in the antioxidant
properties of these compounds. Virgili et al. [21] studied the
e¡ect of PYC on NF-UB activation and NO production in
IFN-Q+LPS-stimulated murine macrophages using the same
cell line. In IFN-Q+LPS-stimulated RAW 264.7 cells, PYC
had no e¡ect on NF-UB activation. PYC pretreatment was
started 24 h before the IFN-Q+LPS administration. However,
in the present experiment cells were pretreated with PYC only
1 h before the stimulation with IFN-Q. Possibly, both the
duration of PYC pretreatment and the characteristic of the
activating signal (IFN-Q+LPS vs. IFN-Q) are important in
terms of PYC-induced changes in NF-UB-dependent gene ex-
pression in activated murine macrophages.
4.4. Conclusion
Flavonoids constitute a large group of phenolic phytochem-
icals with antioxidant properties in vitro. Despite an increas-
ing number of publications concerning free radical-scavenging
and hydrogen-donating activities of £avonoids [15], little is
known about their biological activity in terms of cell signaling
and gene expression. The present data show for the ¢rst time
that monomeric, dimeric, and trimeric £avonoids as well as
PYC display a selective activity in terms of TNF-K secretion,
NO production and NF-UB-dependent gene expression in
RAW 264.7 macrophages. In addition, the present ¢ndings
suggest that the degree of polymerization of £avonoids seems
to be important in determining the mechanism(s) by which
£avonoids may exert their immunomodulatory and antiin-
£ammatory activity. The concentrations of £avonoids used
in the present study are higher than those readily available
in food sources such as tea [31] or chocolate [36]. However,
concentrated forms of plant extracts are now being made
available thereby opening the possibility of achieving concen-
trations equivalent to those supplemented in the present in-
vestigation.
Acknowledgements: G.R. is supported by a grant from the German
Research Society (DFG Forschungsstipendium Ri 884/3-1). The au-
thors are grateful to Dr. Kuni Takayama, Mycobacteriology Research
Laboratory, William S. Middleton Memorial Veterans Hospital,
Madison, WI, USA for providing the lipid A analysis and extend
their gratitude to Dr. Takashi Okamoto, Department of Molecular
Genetics, Nagoya City University, Medical School, Nagoya, Japan
for providing the plasmid pGL3-4UB-Luc.
References
[1] Ignarro, L.J. (1994) Adv. Pharmacol. 26, 35^65.
[2] Beckman, J.S. and Koppenol, W.H. (1996) Am. J. Physiol. 271,
C1424^1437.
[3] Sies, H. and Mehlhorn, R. (1986) Arch. Biochem. Biophys. 251,
393^396.
[4] Ji, Y., Akerboom, T.P., Sies, H. and Thomas, J.A. (1999) Arch.
Biochem. Biophys. 362, 67^78.
[5] Moncada, S., Palmer, R.M. and Higgs, E.A. (1991) Pharmacol.
Rev. 43, 109^142.
[6] Arteel, G.E., Briviba, K. and Sies, H. (1999) FEBS Lett. 445,
226^230.
[7] Stuehr, D.J. and Marletta, M.A. (1987) J. Immunol. 139, 518^
525.
[8] Narumi, S., Finke, J.H. and Hamilton, T.A. (1990) J. Biol.
Chem. 265, 7036^7041.
[9] Green, S.J., Crawford, R.M., Hockmeyer, J.T., Meltzer, M.S.
and Nacy, C.A. (1990) J. Immunol. 145, 4290^4297.
[10] Jun, C.D., Choi, B.M., Kim, H.M. and Chung, H.T. (1995)
J. Immunol. 154, 6541^6547.
[11] Kopp, E.B. and Ghosh, S. (1995) Adv. Immunol. 58, 1^27.
[12] Flohe, L., Brigelius-Flohe, R., Saliou, C., Traber, M.G. and
Packer, L. (1997) Free Radical Biol. Med. 22, 1115^1126.
[13] Saliou, C., Kitazawa, M., McLaughlin, L., Yang, J.P., Lodge,
J.K., Tetsuka, T., Iwasaki, K., Cillard, J., Okamoto, T. and
Packer, L. (1999) Free Radical Biol. Med. 26, 174^183.
[14] Poderoso, J.J., Carreras, M.C., Schopfer, F., Lisdero, C.L., Rio-
bo, N.A., Giulivi, C., Boveris, A.D., Boveris, A. and Cadenas, E.
(1999) Free Radical Biol. Med. 26, 925^935.
[15] Rice-Evans, C.A., Miller, N.J. and Paganga, G. (1996) Free Rad-
ical Biol. Med. 20, 933^956.
[16] Rice-Evans, C.A. and Miller, N.J. (1996) Biochem. Soc. Trans.
24, 790^795.
[17] Packer, L., Rimbach, G. and Virgili, F. (1999) Free Radical Biol.
Med. 27, 704^724.
[18] Cossins, E., Lee, R. and Packer, L. (1998) Biochem. Mol. Biol.
Int. 45, 583^597.
[19] Virgili, F., Kim, D. and Packer, L. (1998) FEBS Lett. 431, 315^
318.
[20] Rimbach, G., Virgili, F., Park, Y.C. and Packer, L. (1999) Redox
Rep. (in press).
[21] Virgili, F., Kobuchi, H. and Packer, L. (1998) Free Radical Biol.
Med. 24, 1120^1129.
[22] Babich, H., Zuckerbraun, H.L., Wurzburger, B.J., Rubin, Y.L.,
Borenfreund, E. and Blau, L. (1996) Toxicology 106, 187^196.
[23] Scuderi, P., Sterling, K.E., Lam, K.S., Finley, P.R., Ryan, K.J.,
Ray, C.G., Petersen, E., Slymen, D.J. and Salmon, S.E. (1986)
Lancet 2, 1364^1365.
[24] Green, L.C., Wagner, D.A., Glogowski, J., Skipper, P.L., Wish-
nok, J.S. and Tannenbaum, S.R. (1982) Anal. Biochem. 126,
131^138.
[25] Carreras, M.C., Poderoso, J.J., Cadenas, E. and Boveris, A.
(1996) Methods Enzymol. 269, 65^75.
[26] Saliou, C., Rihn, B., Cillard, J., Okamoto, T. and Packer, L.
(1998) FEBS Lett. 440, 8^12.
[27] Qureshi, N., Takayama, K., Mascagni, P., Honovich, J., Wong,
R. and Cotter, R.J. (1988) J. Biol. Chem. 263, 11971^11976.
[28] Park, Y.C., Lee, C.H., Kang, H.S., Chung, H.T. and Kim, H.D.
(1997) Biochem. Biophys. Res. Commun. 240, 692^696.
[29] Futami, H., Eader, L.A., Komschlies, K.L., Bull, R., Gruys,
M.E., Ortaldo, J.R., Young, H.A. and Wiltrout, R.H. (1991)
Cancer Res. 51, 6596^6602.
[30] Wadsworth, T.L. and Koop, D.R. (1999) Biochem. Pharmacol.
57, 941^949.
[31] Yang, F., de Villiers, W.J., McClain, C.J. and Varilek, G.W.
(1998) J. Nutr. 128, 2334^2340.
[32] Kobuchi, H., Virgili, F. and Packer, L. (1999) Methods Enzymol.
301, 504^513.
[33] Azumi, S., Tanimura, A. and Tanamoto, K. (1997) Biochem.
Biophys. Res. Commun. 234, 506^510.
[34] Mizutani, A., Maki, H., Torii, Y., Hitomi, K. and Tsukagoshi,
N. (1998) Nitric Oxide 2, 235^241.
[35] Plumb, G.W., De Pascual-Teresa, S., Santos-Buelga, C., Chey-
nier, V. and Williamson, G. (1998) Free Radical Res. 29, 351^
358.
[36] Arts, I.C.W., Hollman, P.C.H. and Kromhout, D. (1999) Lancet
354, 488.
FEBS 23162 30-12-99
Y.C. Park et al./FEBS Letters 465 (2000) 93^97 97
